share_log

Sensei Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Newtyn Management, LLC(6.5%),Newtyn Capital Partners, LP(6.5%), etc.

Sensei Biotherapeutics | SC 13D:超過5%持股股東披露文件-Newtyn Management, LLC(6.5%),Newtyn Capital Partners, LP(6.5%)等

SEC announcement ·  2023/11/03 17:03
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息